Barbora Echalar is affiliated with the Department of Nanotoxicology and Molecular Epidemiology at the Institute of Experimental Medicine of the Czech Academy of Sciences, located in Prague, Czech Republic. Additionally, she is associated with the Department of Cell Biology at the Faculty of Science, Charles University, also in Prague.
Research Contributions
Barbora Echalar has significantly contributed to the field of mesenchymal stem cells (MSCs). Her research primarily focuses on the behavior and potential therapeutic applications of MSCs. In a 2022 study, she explored the inability of ex vivo expanded MSCs to survive in newborn mice and to induce transplantation tolerance. Another notable study from 2021 investigated the altered migration and distribution of systemically administered MSCs in morphine-treated recipients. These contributions indicate her active role in advancing our understanding of MSCs in various biological and clinical contexts.
